Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: Results of an international randomized phase II trial (JASINT1)

Maria De Santis, P. J. Wiechno, J. Bellmunt, C. Lucas, W. C. Su, L. Albiges, C. C. Lin, E. Senkus-Konefka, A. Flechon, L. Mourey, A. Necchi, W. C. Loidl, M. M. Retz, N. Vaissière, S. Culine

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: Results of an international randomized phase II trial (JASINT1)'. Together they form a unique fingerprint.

Medicine & Life Sciences